Instrumento Inactivo

Otros idiomas Canopy Growth Corp Toronto S.E.

Acciones

CGC

CA1380351009

Farmacéuticos

Precio de cierre Toronto S.E. Otros sitios de cotización
- ^CAD	-

29/05	Canopy Growth Corporation relanza la marca Tweed en Alemania con una nueva línea de variedades de cannabis de MTL	CI
29/05	Canopy Growth relanza la marca Tweed en Alemania con una nueva gama de cepas de MTL Cannabis, marcando el primer lanzamiento internacional tras la adquisición	RE

Otros idiomas

08/06	Canopy Growth Announces Claybourne’s Frosted Flyers Wins ‘Best Infused Pre-Roll' at 2026 Grow Up Awards
29/05	Canopy Growth Corporation Relaunches Tweed Brand in Germany with New Mtl Cannabis Strain Lineup
29/05	Canopy Growth relaunches Tweed brand in Germany with new MTL Cannabis strain lineup, marking first international release following acquisition
29/05	Canopy Growth Relaunches Tweed Brand in Germany With New MTL Cannabis Strain Lineup
29/05	Canopy Growth Relaunches Tweed Brand In Germany; Introduces MTL Cannabis Strains
29/05	Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition
18/05	Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
15/05	Canopy Growth Adds "No Impact on Core Operating Performance"
15/05	Canopy Growth Says During YE Financial Reporting Process For Fiscal Year Ended March 31, 2026, the Co Identified a Technical Non-cash Accounting Error
15/05	Canopy Growth Also Plans to File Restated Financials for Fiscal Years Ended March 31, 2025 and March 31, 2024 and Certain Interim Periods
15/05	Canopy Growth Expects to Release Financial Results for Quarter and Fiscal Year Ended March 31, 2026, Before Markets Open on June 15, 2026
15/05	Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
14/05	Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
07/05	Canopy Growth and Spectrum Therapeutics Expanding Medical Portfolio With New 30 And 90-Pack Softgels and Enhanced Dosing Options
07/05	Canopy Growth and Spectrum Therapeutics expand medical portfolio with new 30 and 90-pack softgels and enhanced dosing options
07/05	Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
07/05	Canopy Growth Corporation and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
30/04	Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
23/04	Health Care Down, but Not by Much, as Cannabis Cos Rise -- Health Care Roundup
23/04	TSX Closer: Index Down As News of U.S. Reclassification Fails To Keep Fire Burning Under Cannabis Stocks
23/04	Pot firms reverse gains on narrow scope of US rescheduling
23/04	Les États-Unis reclassent le cannabis dans une catégorie moins restrictive
23/04	Les USA reclassent le cannabis dans une catégorie moins restrictive
23/04	US reclassifies certain marijuana products as a less-dangerous drug
23/04	Wall St slips on Middle East impasse, mixed earnings